JP4932995B2 - 改良されたリン酸化方法及びこの方法により製造される化合物 - Google Patents

改良されたリン酸化方法及びこの方法により製造される化合物 Download PDF

Info

Publication number
JP4932995B2
JP4932995B2 JP2000618282A JP2000618282A JP4932995B2 JP 4932995 B2 JP4932995 B2 JP 4932995B2 JP 2000618282 A JP2000618282 A JP 2000618282A JP 2000618282 A JP2000618282 A JP 2000618282A JP 4932995 B2 JP4932995 B2 JP 4932995B2
Authority
JP
Japan
Prior art keywords
temperature
complex
steps
acid
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2000618282A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003526623A5 (https=
JP2003526623A (ja
Inventor
マイケル ウエスト，シモン
Original Assignee
バイタル ヘルス サイエンシズ プロプライアタリー リミティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/AU2000/000038 external-priority patent/WO2000043380A1/en
Application filed by バイタル ヘルス サイエンシズ プロプライアタリー リミティド filed Critical バイタル ヘルス サイエンシズ プロプライアタリー リミティド
Priority claimed from PCT/AU2000/000452 external-priority patent/WO2000069865A1/en
Publication of JP2003526623A publication Critical patent/JP2003526623A/ja
Publication of JP2003526623A5 publication Critical patent/JP2003526623A5/ja
Application granted granted Critical
Publication of JP4932995B2 publication Critical patent/JP4932995B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/11—Esters of phosphoric acids with hydroxyalkyl compounds without further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65611—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
JP2000618282A 1999-05-14 2000-05-12 改良されたリン酸化方法及びこの方法により製造される化合物 Expired - Lifetime JP4932995B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
AUPQ0374A AUPQ037499A0 (en) 1999-05-14 1999-05-14 Improved process for phosphorylation and compounds produced by this method
AU0374 1999-05-14
AUPQ0374 1999-05-14
AU0000038 2000-01-25
PCT/AU2000/000038 WO2000043380A1 (en) 1999-01-25 2000-01-25 Recovery of chroman derivatives
AUAU0000038 2000-01-25
PCT/AU2000/000452 WO2000069865A1 (en) 1999-05-14 2000-05-12 Improved process for phosphorylation and compounds produced by this process

Publications (3)

Publication Number Publication Date
JP2003526623A JP2003526623A (ja) 2003-09-09
JP2003526623A5 JP2003526623A5 (https=) 2007-06-28
JP4932995B2 true JP4932995B2 (ja) 2012-05-16

Family

ID=3814578

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000618282A Expired - Lifetime JP4932995B2 (ja) 1999-05-14 2000-05-12 改良されたリン酸化方法及びこの方法により製造される化合物

Country Status (7)

Country Link
US (1) US6579995B1 (https=)
JP (1) JP4932995B2 (https=)
KR (1) KR20020013876A (https=)
AT (1) ATE377015T1 (https=)
AU (1) AUPQ037499A0 (https=)
BR (1) BR0011523B1 (https=)
DE (1) DE60036940T2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60140141D1 (de) * 2000-11-14 2009-11-19 Vital Health Sciences Pty Ltd Zusammensetzungen umfassend Komplexe von Tocopherolphosphatderivaten
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
BR0211673A (pt) * 2001-07-27 2004-07-13 Vital Health Sciences Pty Ltd Terapia dermal utilizando derivados de fosfato de agentes de transferência de elétrons
ATE487456T1 (de) * 2001-12-13 2010-11-15 Vital Health Sciences Pty Ltd Transdermaler transport von verbindungen
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
EP1589964B1 (en) * 2003-01-17 2011-11-23 Vital Health Sciences Pty Ltd. Compounds having anti-proliferative properties
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
JP4847437B2 (ja) * 2004-03-03 2011-12-28 バイタル ヘルス サイエンシズ プロプライアタリー リミティド アルカロイド製剤
BRPI0513673B8 (pt) * 2004-08-03 2021-07-27 Vital Health Sciences Pty Ltd método para produzir um medicamento para aumentar a eficácia e o transporte dos compostos biologicamente ativos enteralmente administrados, e composição farmacêutica
WO2006092024A1 (en) * 2005-03-03 2006-09-08 Vital Health Sciences Pty Ltd Compounds having anti-cancer properties
US9168216B2 (en) * 2005-06-17 2015-10-27 Vital Health Sciences Pty. Ltd. Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
WO2007070981A1 (en) * 2005-12-23 2007-06-28 Vital Health Sciences Pty Ltd Compounds having cytokine modulating properties
US8728990B2 (en) 2009-12-04 2014-05-20 Elementis Specialties, Inc. Phosphate ester oil gellant
EP2531047B1 (en) 2010-02-05 2024-11-13 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
ES2829386T3 (es) 2010-03-30 2021-05-31 Phosphagenics Ltd Parche de administración transdérmica
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
MX383940B (es) 2015-12-09 2025-03-14 Phosphagenics Ltd Formulación farmacéutica que contiene tocol fosfato.
IL267006B2 (en) * 2016-12-21 2024-11-01 Phosphagenics Ltd Process for phosphorylation of a complex alcohol with p4o10 at high temperatures, and products thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5022535B1 (https=) * 1970-05-12 1975-07-31
JPS5239013B1 (https=) * 1970-05-21 1977-10-03
JPS6393791A (ja) * 1986-10-08 1988-04-25 Nippon Shokubai Kagaku Kogyo Co Ltd リン酸エステルおよびその製法
JPH08231564A (ja) * 1995-02-28 1996-09-10 Nippon Shokubai Co Ltd リン酸エステルおよびその製造方法並びにリン酸エステル重合体
JPH1045783A (ja) * 1996-07-29 1998-02-17 Showa Denko Kk ヒドロキシクロマン誘導体リン酸エステルの製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141938A (en) 1976-10-07 1979-02-27 Hoechst Aktiengesellschaft Production of acid orthophosphoric acid ester mixtures
JPH0247997B2 (ja) 1983-02-25 1990-10-23 Sanyo Chemical Ind Ltd Rinsanesuterunoseizoho
JPS62195393A (ja) 1986-02-21 1987-08-28 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体およびその製造方法
DE3702766A1 (de) 1987-01-30 1988-08-11 Henkel Kgaa Verfahren zur herstellung und isolierung von monoalkylphosphorsaeureestern
IT1236843B (it) * 1989-11-22 1993-04-21 Simes Processo per la preparazione di 4-0-fosfati di dopamina o suoi derivati
US5741518A (en) * 1992-08-03 1998-04-21 L'oreal Composition composed of an aqueous dispersion of stabilized vesicles of nonionic amphiphilic lipids
US5554781A (en) * 1994-03-30 1996-09-10 Reierson; Robert L. Monoalkyl phosphonic acid ester production process
JPH07316170A (ja) 1994-05-24 1995-12-05 Kao Corp リン酸モノエステルの製造法
JP3526940B2 (ja) 1995-01-11 2004-05-17 花王株式会社 リン酸エステルの製造法
FR2730928B1 (fr) * 1995-02-23 1997-04-04 Oreal Composition a base de vesicules lipidiques a ph acide et son utilisation en application topique
JP3197787B2 (ja) 1995-05-17 2001-08-13 花王株式会社 分岐二量化アルキルリン酸塩基性アミノ酸塩の製造方法
FR2741263B1 (fr) * 1995-11-22 1997-12-26 Oreal Composition comprenant une dispersion aqueuse de vesicules lipidiques encapsulant un filtre uv a fonction acide et utilisations en application topique

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5022535B1 (https=) * 1970-05-12 1975-07-31
JPS5239013B1 (https=) * 1970-05-21 1977-10-03
JPS6393791A (ja) * 1986-10-08 1988-04-25 Nippon Shokubai Kagaku Kogyo Co Ltd リン酸エステルおよびその製法
JPH08231564A (ja) * 1995-02-28 1996-09-10 Nippon Shokubai Co Ltd リン酸エステルおよびその製造方法並びにリン酸エステル重合体
JPH1045783A (ja) * 1996-07-29 1998-02-17 Showa Denko Kk ヒドロキシクロマン誘導体リン酸エステルの製造方法

Also Published As

Publication number Publication date
US6579995B1 (en) 2003-06-17
BR0011523B1 (pt) 2014-09-30
DE60036940T2 (de) 2008-08-14
ATE377015T1 (de) 2007-11-15
DE60036940D1 (de) 2007-12-13
AUPQ037499A0 (en) 1999-06-10
BR0011523A (pt) 2002-03-26
JP2003526623A (ja) 2003-09-09
KR20020013876A (ko) 2002-02-21

Similar Documents

Publication Publication Date Title
JP4932995B2 (ja) 改良されたリン酸化方法及びこの方法により製造される化合物
EP0127471B1 (en) Phosporic acid diesters, their salts, compositions containing them and a process for producing said diesters and salts
Higgins et al. Aromatic phosphinic acids and derivatives. I. Diphenylphosphinodithoic acid and its derivatives
CN1037341A (zh) 抗坏血酸-2-磷酸酯
CA2372066C (en) Process for phosphorylation of primary fatty alcohols,secondary alcohols and aromatic alcohols using p4o10 in the absence of solvent
JPH0529235B2 (https=)
JP3102798B2 (ja) イノシトールの誘導体、それを含む製剤及びそれらの使用法
US4110441A (en) Gamma-l-glutamyl cholamine phosphate
EP0417604B1 (de) Verfahren zur Herstellung von Riboflavin-5'-phosphat bzw. dessen Natriumsalz
US2457932A (en) Salts of tocopheryl phosphoric
KR20160052905A (ko) 이온 교환수지를 이용한 개선된 테노포비르 디소프록실 푸마레이트 합성방법 및 이를 이용한 구강 붕해 필름(odf)제형의 제조방법
US5420302A (en) Preparation of calcium L-ascorbate 2-phosphate
AU766255B2 (en) Improved process for phosphorylation and compounds produced by this process
Weiss Synthesis of Several Phosphorylated Derivatives of Dihydrosphingosine1
WO1989010370A1 (fr) Nouvelles alkylphosphono- et phosphoserines, procede pour leur preparation, et substances pharmaceutiques les contenant
US3975405A (en) Monophosphate salt of o-cresolphthalein
CN115197292B (zh) 一种雌酮磷酸酯及其盐的制备方法和应用
JP3190434B2 (ja) 濾過容易な、粗結晶性リボフラビン−５′−リン酸−１ナトリウム塩の製法
DE69807464T2 (de) Diester-derivate von acyclovir
EP1370565A2 (de) Verfahren zur herstellung von 1-hydroxy-1, 1-diphosphonsäureverbindungen
JP2004536872A (ja) アスコルビン酸−３リン酸の安定化誘導体
DE60007201T2 (de) Verfahren zur Herstellung von Ascorbinsaüre-2-Monophosphat salz
CA1072969A (en) Hypolipidemic p-aminobenzoic acids
EP1174435A2 (de) Verfahren zur Herstellung von Platin-Alkenylpolysiloxan-Komplexen, insbesondere von Platin-Divinyltetramethyldisiloxan
JP3171279B2 (ja) 炭素原子数１４〜１８を有するアルキルホスホコリンの製法及びアルキルホスホコリンの精製法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070508

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070508

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100329

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100406

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100628

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100705

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101006

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110426

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110722

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120117

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120216

R150 Certificate of patent or registration of utility model

Ref document number: 4932995

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150224

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term